Skip to main content Back to Top
Advertisement

8/3/2019

Clonidine Hydrochloride Injection

Products Affected - Description

    • Clonidine hydrochloride, X-Gen, 0.1 mg/mL, 10 mL vial, 1 count, NDC 39822-2000-01
    • Clonidine hydrochloride, X-Gen, 0.5 mg/mL, 10 mL vial, 1 count, NDC 39822-2010-01

Reason for the Shortage

    • American Regent and Fresenius Kabi are not currently marketing clonidine injection.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional refuses to provide availability information.
    • X-Gen did not provide a reason for the shortage.

Available Products

    • Clonidine hydrochloride, Hikma, 0.1 mg/mL, 10 mL vial, 1 count, NDC 00143-9724-01
    • Clonidine hydrochloride, Hikma, 0.5 mg/mL, 10 mL vial, 1 count, NDC 00143-9723-01

Estimated Resupply Dates

    • X-Gen has clonidine 0.5 mg/mL 10 mL vials and 0.1 mg/mL 10 mL vials on intermittent back order with regular releases.

Updated

Updated August 3, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 9, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins